{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:24:25Z","timestamp":1770751465405,"version":"3.50.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04569-8","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:34:48Z","timestamp":1765460088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salbutamol in Congenital Myasthenic Syndrome: A Systematic Review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9511-9131","authenticated-orcid":false,"given":"Muhammad","family":"Takhman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8028-503X","authenticated-orcid":false,"given":"Reem","family":"Shihab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2835-0429","authenticated-orcid":false,"given":"Moath","family":"Hattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5054-5571","authenticated-orcid":false,"given":"Hala O.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8968-7034","authenticated-orcid":false,"given":"Mohammad","family":"Bdair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernan D.","family":"Gonorazky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-0038","authenticated-orcid":false,"given":"Issa","family":"Alawneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"4569_CR1","doi-asserted-by":"crossref","unstructured":"Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019;14(1):57. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6390566\/. Cited 2025 Nov 25.","DOI":"10.1186\/s13023-019-1025-5"},{"key":"4569_CR2","doi-asserted-by":"crossref","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14(4):420. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4520251\/. Cited 2025 Sep 3.","DOI":"10.1016\/S1474-4422(14)70201-7"},{"key":"4569_CR3","doi-asserted-by":"crossref","unstructured":"Gilhus NE. Myasthenia gravis and congenital myasthenic syndromes. Handb Clin Neurol. 2023;195:635\u201352. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/B9780323988186000108?via%3Dihub. Cited 2025 Sep 3.","DOI":"10.1016\/B978-0-323-98818-6.00010-8"},{"key":"4569_CR4","doi-asserted-by":"crossref","unstructured":"Engel AG. The Therapy of Congenital Myasthenic Syndromes. Neurotherapeutics. 2007;4(2):252\u20137. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1878747923006554. Cited 2025 Sep 3.","DOI":"10.1016\/j.nurt.2007.01.001"},{"key":"4569_CR5","doi-asserted-by":"crossref","unstructured":"Vanhaesebrouck AE, Beeson D. The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies. Curr Opin Neurol. 2019;32(5):696. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6735524\/. Cited 2025 Sep 3.","DOI":"10.1097\/WCO.0000000000000736"},{"key":"4569_CR6","doi-asserted-by":"crossref","unstructured":"Thompson R, Bonne G, Missier P, Lochm\u00fcller H. Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome. Emerg Top Life Sci. 2019;3(1):19. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6436731\/. Cited 2025 Sep 3.","DOI":"10.1042\/ETLS20180100"},{"key":"4569_CR7","unstructured":"Beeson D. Congenital myasthenic syndromes. Handb Clin Neurol. 2024;203:69\u201388. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/B9780323908207000136?via%3Dihub. Cited 2025 Sep 3."},{"key":"4569_CR8","unstructured":"Salbutamol | C13H21NO3 | CID 2083 - PubChem.. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Salbutamol. Cited 2025 Sep 3."},{"key":"4569_CR9","doi-asserted-by":"crossref","unstructured":"Webster RG, Vanhaesebrouck AE, Maxwell SE, Cossins JA, Liu W, Ueta R, et al. Effect of Salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia. Hum Mol Genet. 2020;29(14):2325. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7424765\/. Cited 2025 Sep 3.","DOI":"10.1093\/hmg\/ddaa116"},{"key":"4569_CR10","doi-asserted-by":"crossref","unstructured":"Burke G, Hiscock A, Klein A, Niks EH, Main M, Manzur AY, et al. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscular Disorders. 2013;23(2):170\u20135. Available from: https:\/\/www.nmd-journal.com\/action\/showFullText?pii=S0960896612006712. Cited 2025 Sep 3.","DOI":"10.1016\/j.nmd.2012.11.004"},{"issue":"2","key":"4569_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mus.23534","volume":"47","author":"S Finlayson","year":"2013","unstructured":"Finlayson S, Spillane J, Kullmann DM, Howard R, Webster R, Palace J, et al. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol. Muscle Nerve. 2013;47(2):279\u201382. https:\/\/doi.org\/10.1002\/mus.23534.","journal-title":"Muscle Nerve"},{"key":"4569_CR12","doi-asserted-by":"crossref","unstructured":"Jiang K, Zheng Y, Lin J, Wu X, Yu Y, Zhu M, et al. Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation. Brain Behav. 2022;12(2):e2469. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8865156\/. Cited 2025 Sep 6.","DOI":"10.1002\/brb3.2469"},{"key":"4569_CR13","doi-asserted-by":"crossref","unstructured":"Rasmussen M, Antal EA, \u00d8rstavik K, Popperud T, Kamsteeg EJ. Congenital myasthenic syndrome with positive response to Salbutamol treatment. European Journal of Paediatric Neurology. 2017;21:e226\u20137. Available from: https:\/\/www.ejpn-journal.com\/action\/showFullText?pii=S1090379817314952. Cited 2025 Sep 6.","DOI":"10.1016\/j.ejpn.2017.04.1236"},{"key":"4569_CR14","doi-asserted-by":"publisher","unstructured":"Palmio J, Kiviranta P, Hartikainen PH, Isohanni P, Auranen M, Videman K, et al. Homozygosity of a Founder Variant c.1508dupC in DOK7 Causes Congenital Myasthenia With Variable Severity. Neurol Genet. 2024;10(3):e200155. Available from: https:\/\/www.neurology.org\/doi\/pdf\/https:\/\/doi.org\/10.1212\/NXG.0000000000200155. Cited 2025 Sep 6.","DOI":"10.1212\/NXG.0000000000200155"},{"key":"4569_CR15","doi-asserted-by":"crossref","unstructured":"Tomsa C, Viccaro F, Panza L, D\u2019Antoni L, Palange P. Effective treatment with oral Salbutamol on late onset respiratory impairment in a DOK7 Congenital Myasthenia Syndrome: a case report. Multidiscip Respir Med. 2024;19(1):942. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11186440\/. Cited 2025 Sep 6.","DOI":"10.5826\/mrm.2024.942"},{"key":"4569_CR16","doi-asserted-by":"crossref","unstructured":"Lozowska D, Ringel SP, Winder TL, Liu J, Liewluck T. Anticholinesterase therapy worsening head drop and limb weakness due to a novel DOK7 mutation. J Clin Neuromuscul Dis. 2015;17(2):72\u20137. Available from: https:\/\/journals.lww.com\/jcnmd\/fulltext\/2015\/12000\/anticholinesterase_therapy_worsening_head_drop_and.6.aspx. Cited 2025 Sep 6.","DOI":"10.1097\/CND.0000000000000095"},{"key":"4569_CR17","doi-asserted-by":"crossref","unstructured":"Burke G, Hiscock A, Klein A, Niks EH, Main M, Manzur AY, et al. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscular Disorders. 2013;23(2):170\u20135. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0960896612006712. Cited 2025 Sep 6.","DOI":"10.1016\/j.nmd.2012.11.004"},{"key":"4569_CR18","doi-asserted-by":"crossref","unstructured":"Jadhav T, Shah P, Karnavat PK, Hegde AU. Intrafamilial variation in clinical manifestations and response to Salbutamol in siblings with congenital myasthenic syndrome caused by DOK7 mutations. Journal of the International Child Neurology Association. 2019.","DOI":"10.17724\/jicna.2019.122"},{"key":"4569_CR19","doi-asserted-by":"crossref","unstructured":"Tsao CY. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children. Pediatr Neurol. 2016;54:85\u20137. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0887899415301053. Cited 2025 Sep 6.","DOI":"10.1016\/j.pediatrneurol.2015.09.019"},{"key":"4569_CR20","doi-asserted-by":"crossref","unstructured":"Nouri Z, Saffari-Chaleshtori J, Sarmadi A, Sehhati M, Tabatabaiefar MA. Clinical and molecular analysis of a novel variant responsive to Salbutamol monotherapy during COVID-19 outbreak related to congenital and late-onset of myasthenic syndrome in large kindred. 2024; Available from: https:\/\/www.researchsquare.com. Cited 2025 Sep 6.","DOI":"10.21203\/rs.3.rs-3924937\/v1"},{"key":"4569_CR21","doi-asserted-by":"crossref","unstructured":"Bevilacqua JA, Lara M, D\u00edaz J, Campero M, V\u00e1szquez J, Maselli RA. Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile. Eur J Transl. 2017;27(3):6832. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5658635\/. Cited 2025 Sep 7.","DOI":"10.4081\/ejtm.2017.6832"},{"key":"4569_CR22","doi-asserted-by":"crossref","unstructured":"Mahjneh I, Lochm\u00fcller H, Muntoni F, Abicht A. DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy. Neuromuscular Disorders. 2013;23(1):36\u201342. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0960896612005585. Cited 2025 Sep 7.","DOI":"10.1016\/j.nmd.2012.06.355"},{"key":"4569_CR23","doi-asserted-by":"crossref","unstructured":"Alsallum MS, Alshareef A, Abuzinadah AR, Bamaga AK, Dallol A. A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members. Heliyon. 2021;7(5):e06869. Available from: https:\/\/www.cell.com\/action\/showFullText?pii=S2405844021009725. Cited 2025 Sep 7.","DOI":"10.1016\/j.heliyon.2021.e06869"},{"key":"4569_CR24","doi-asserted-by":"crossref","unstructured":"Gomathy SB, Das A, Garg A, Srivastava AK. Congenital Myasthenic Syndrome Caused by DOK7 Mutation in a Quinquagenarian Male with Calf Hypertrophy. J Clin Neuromuscul Dis. 2023;25(1):51\u20134. Available from: https:\/\/journals.lww.com\/jcnmd\/fulltext\/2023\/09000\/congenital_myasthenic_syndrome_caused_by_dok7.8.aspx. Cited 2025 Sep 7.","DOI":"10.1097\/CND.0000000000000448"},{"key":"4569_CR25","doi-asserted-by":"crossref","unstructured":"Khadilkar S, Bhutada A, Nallamilli B, Hegde M. Limb girdle weakness responding to Salbutamol: An Indian family with DOK7 mutation. Indian Pediatr. 2015;52(3):243\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25849006\/. Cited 2025 Sep 7.","DOI":"10.1007\/s13312-015-0616-z"},{"key":"4569_CR26","doi-asserted-by":"crossref","unstructured":"Yin Y, Cao J, Fan Y, Xu Y. COLQ-mutation congenital myasthenic syndrome in late adolescence: Case report and review of the literature. Heliyon. 2023;9(9):e19980. Available from: https:\/\/www.cell.com\/action\/showFullText?pii=S2405844023071888. Cited 2025 Sep 7.","DOI":"10.1016\/j.heliyon.2023.e19980"},{"key":"4569_CR27","doi-asserted-by":"publisher","unstructured":"El Kadiri Y, Ratbi I, Sefiani A, Lyahyai J. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature. BMC Neurol. 2022;22(1):1\u20139. Available from: https:\/\/bmcneurol.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12883-022-02822-y. Cited 2025 Sep 7.","DOI":"10.1186\/s12883-022-02822-y"},{"key":"4569_CR28","doi-asserted-by":"crossref","unstructured":"Khaoula R, Cerino M, Da Silva N, Delague V, Nahili H, Kriouile Y, et al. First characterization of congenital myasthenic syndrome type 5 in North Africa. Mol Biol Rep. 2024;48(10):6999\u20137006. Available from: https:\/\/amu.hal.science\/hal-03662463. Cited 2025 Sep 7.","DOI":"10.1007\/s11033-021-06530-7"},{"key":"4569_CR29","doi-asserted-by":"crossref","unstructured":"Bogdanova-Mihaylova P, Murphy RPJ, Alexander MD, McHugh JC, Foley AR, Brett F, et al. Congenital myasthenic syndrome due to DPAGT1 mutations mimicking congenital myopathy in an Irish family. Eur J Neurol. 2018;25(2):e22\u20133. Available from: https:\/\/www.researchgate.net\/publication\/351346371_Congenital_myasthenic_syndrome_due_to_DPAGT1_mutations_mimicking_congenital_myopathy_in_an_Irish_family. Cited 2025 Sep 7.","DOI":"10.1111\/ene.13532"},{"key":"4569_CR30","doi-asserted-by":"crossref","unstructured":"Gallenm\u00fcller C, Felber WM, Dusl M, Stucka R, Guergueltcheva V, Blaschek A, et al. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. Neuromuscular Disorders.;24(1):31\u20135. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0960896613009334. Cited 2025 Sep 7.","DOI":"10.1016\/j.nmd.2013.08.002"},{"issue":"7","key":"4569_CR31","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/ajmg.a.38707","volume":"176","author":"D Owen","year":"2018","unstructured":"Owen D, T\u00f6pf A, Preethish-Kumar V, Lorenzoni PJ, Vroling B, Scola RH, et al. Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness. Am J Med Genet A. 2018;176(7):1594\u2013601.","journal-title":"Am J Med Genet A"},{"key":"4569_CR32","doi-asserted-by":"crossref","unstructured":"Pinto M V., Saw JL, Milone M. Congenital Vocal Cord Paralysis and Late-Onset Limb-Girdle Weakness in MuSK\u2013Congenital Myasthenic Syndrome. Front Neurol. 2019;10:502283. Available from: www.frontiersin.org. Cited 2025 Sep 7.","DOI":"10.3389\/fneur.2019.01300"},{"key":"4569_CR33","doi-asserted-by":"crossref","unstructured":"Mukhtiar K, Raza M, Tejani I, Ali F, Ibrahim S. Diagnostic dilemmas and challenges in the management of myasthenia in infants and toddlers: A case report. SAGE Open Med Case Rep. 2023;11. Available from:\u00a0https:\/\/scholar.google.com\/scholar_url?url=https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X231211047&hl=en&sa=T&oi=ucasa&ct=ufr&ei=X6e8aMuoAfvoieoPtJ70sAg&scisig=AAZF9b_k2C-7SZYfpyPdcEB-dSxl. Cited 2025 Sep 7.","DOI":"10.1177\/2050313X231211047"},{"key":"4569_CR34","doi-asserted-by":"crossref","unstructured":"Mroczek M, Durmus H, T\u00f6pf A, Parman Y, Straub V. Four Individuals with a Homozygous Mutation in Exon 1f of the PLEC Gene and Associated Myasthenic Features. Genes 2020, Vol 11, Page 716. 2020;11(7):716. Available from: https:\/\/www.mdpi.com\/2073-4425\/11\/7\/716\/htm. Cited 2025 Sep 7.","DOI":"10.3390\/genes11070716"},{"key":"4569_CR35","doi-asserted-by":"crossref","unstructured":"Sadeh M, Shen XM, Engel AG. Beneficial Effect of Albuterol in Congential Myasthenic Syndrome with Epsilon Subuint Mutations. Muscle Nerve. 2011;44(2):289. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3136566\/. Cited 2025 Sep 7.","DOI":"10.1002\/mus.22153"},{"key":"4569_CR36","doi-asserted-by":"crossref","unstructured":"Webster R, Liu WW, Chaouch A, Lochm\u00fcller H, Beeson D. Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the \u03b1\u2013\u03b5 subunit interface. Neuromuscular Disorders. 2014;24(2):143\u20137. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0960896613009899. Cited 2025 Sep 7.","DOI":"10.1016\/j.nmd.2013.10.009"},{"key":"4569_CR37","doi-asserted-by":"crossref","unstructured":"Mishra S, Nair KV, Shukla A. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature. Clin Dysmorphol. 2023;32(4):162\u20137. Available from: https:\/\/journals.lww.com\/clindysmorphol\/fulltext\/2023\/10000\/delineation_of_molecular_characteristics_of.4.aspx. Cited 2025 Sep 7.","DOI":"10.1097\/MCD.0000000000000465"},{"key":"4569_CR38","doi-asserted-by":"publisher","unstructured":"Xi J, Yan C, Liu WW, Qiao K, Lin J, Tian X, et al. Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome. Orphanet J Rare Dis. 2017;12(1):1\u20137. Available from: https:\/\/ojrd.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13023-017-0732-z. Cited 2025 Sep 7.","DOI":"10.1186\/s13023-017-0732-z"},{"key":"4569_CR39","doi-asserted-by":"publisher","unstructured":"Jacquier A, Risson V, Simonet T, Roussange F, Lacoste N, Ribault S, et al. Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons. Acta Neuropathol. 2022;144(4):707\u201331. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00401-022-02475-8. Cited 2025 Sep 7.","DOI":"10.1007\/s00401-022-02475-8"},{"key":"4569_CR40","unstructured":"Zhang Y, Dai Y, Han JN, Chen ZH, Ling L, Pu CQ, et al. A novel AGRN mutation leads to congenital myasthenic syndrome only affecting limb-girdle muscle. Chin Med J (Engl). 2017;130(19):2279\u201382. Available from: https:\/\/journals.lww.com\/cmj\/fulltext\/2017\/10050\/a_novel_agrn_mutation_leads_to_congenital.3.aspx. Cited 2025 Sep 7."},{"issue":"14","key":"4569_CR41","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1111\/jcmm.17417","volume":"26","author":"K Huang","year":"2022","unstructured":"Huang K, Duan HQ, Li QX, Luo YB, Bi FF, Yang H. Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre. J Cell Mol Med. 2022;26(14):3828\u201336. https:\/\/doi.org\/10.1111\/jcmm.17417.","journal-title":"J Cell Mol Med"},{"key":"4569_CR42","doi-asserted-by":"publisher","unstructured":"Dusl M, Moreno T, Munell F, Macaya A, Gratac\u00f2s M, Abicht A, et al. Congenital myasthenic syndrome caused by novel COL13A1 mutations. J Neurol. 2019;266(5):1107\u201312. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00415-019-09239-7. Cited 2025 Sep 7.","DOI":"10.1007\/s00415-019-09239-7"},{"issue":"6","key":"4569_CR43","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/brain\/awz107","volume":"142","author":"PM Rodr\u00edguez Cruz","year":"2019","unstructured":"Rodr\u00edguez Cruz PM, Cossins J, De Paula Estephan E, Munell F, Selby K, Hirano M, et al. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. Brain. 2019;142(6):1547\u201360. https:\/\/doi.org\/10.1093\/brain\/awz107.","journal-title":"Brain"},{"issue":"3","key":"4569_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/ncn3.12700","volume":"11","author":"SV Khadilkar","year":"2023","unstructured":"Khadilkar SV, Oza H, Dhonde P, Patel B, Singla M, Patel R, et al. Congenital myasthenic syndromes: a study of 15 cases. Neurology and Clinical Neuroscience. 2023;11(3):127\u201333. https:\/\/doi.org\/10.1111\/ncn3.12700.","journal-title":"Neurology and Clinical Neuroscience"},{"key":"4569_CR45","doi-asserted-by":"publisher","unstructured":"Kim HG, Lee JS, Kim KW, Kang HC, Kim SH. Effects of Salbutamol in Collagen like Tail Subunit of Asymmetric Acetylcholinesterase-Related Congenital Myasthenic Syndrome: A First Korean Case. Annals of Child Neurology. 2020;29(1):54\u20136. Available from: http:\/\/www.annchildneurol.org\/journal\/view.php?doi=https:\/\/doi.org\/10.26815\/acn.2020.00171. Cited 2025 Sep 7.","DOI":"10.26815\/acn.2020.00171"},{"key":"4569_CR46","doi-asserted-by":"crossref","unstructured":"Horibe T, Shimomura H, Tokunaga S, Taniguchi N, Lee T, Kimura S, et al. A Pediatric Case of COLQ-Related Congenital Myasthenic Syndrome with Marked Fatigue. Children 2023, Vol 10, Page 769. 2023;10(5):769. Available from: https:\/\/www.mdpi.com\/2227-9067\/10\/5\/769\/htm. Cited 2025 Sep 7.","DOI":"10.3390\/children10050769"},{"key":"4569_CR47","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Garc\u00eda MI, Guerrero-Molina MP, de Fuenmayor-Fern\u00e1ndez de la Hoz CP, Bermejo-Guerrero L, Arteche-L\u00f3pez A, Hern\u00e1ndez-La\u00edn A, et al. Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies. Journal of Clinical Medicine 2023, Vol 12, Page 3308. 2023;12(9):3308. Available from: https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3308\/htm. Cited 2025 Sep 7.","DOI":"10.3390\/jcm12093308"},{"key":"4569_CR48","doi-asserted-by":"publisher","unstructured":"Banerjee A, Datta Kanjilal S, Biswas T, Ghoshal A, Sarkar S. Congenital myasthenic syndrome: a tale of two siblings. International Journal of Neuroscience. 2024;134(3):253\u20135. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.1080\/00207454.2022.2100774. Cited 2025 Sep 7.","DOI":"10.1080\/00207454.2022.2100774"},{"issue":"9","key":"4569_CR49","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awv185","volume":"138","author":"K Belaya","year":"2015","unstructured":"Belaya K, Rodr\u00edguez Cruz PM, Liu WW, Maxwell S, McGowan S, Farrugia ME, et al. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Brain. 2015;138(9):2493\u2013504. https:\/\/doi.org\/10.1093\/brain\/awv185.","journal-title":"Brain"},{"key":"4569_CR50","doi-asserted-by":"publisher","unstructured":"Polavarapu K, Mathur A, Joshi A, Nashi S, Preethish-Kumar V, Bardhan M, et al. A founder mutation in the\u00a0GMPPB\u00a0gene [c.1000G >A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy\/congenital myasthenic syndrome (LGMD\/CMS) in South Indian patients. Neurogenetics. 2021;22(4):271\u201385. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s10048-021-00658-1. Cited 2025 Sep 7.","DOI":"10.1007\/s10048-021-00658-1"},{"key":"4569_CR51","doi-asserted-by":"crossref","unstructured":"Natera-de Benito D, Pugliese A, Polavarapu K, Guergueltcheva V, Tournev I, Todorova A, et al. Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases. Pediatr Neurol. 2024;157:5\u201313. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0887899424001565. Cited 2025 Sep 7.","DOI":"10.1016\/j.pediatrneurol.2024.04.027"},{"key":"4569_CR52","doi-asserted-by":"publisher","unstructured":"Ylldlrlm M, Yarenci GB, Gen\u00e7 MB, U\u00e7ar \u00c7\u0130, Bayav S, Tekin MN, et al. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review. Neuropediatrics. 2024;55(3):200\u20134. Available from: http:\/\/www.thieme-connect.com\/products\/ejournals\/html\/https:\/\/doi.org\/10.1055\/s-0044-1782675. Cited 2025 Sep 7.","DOI":"10.1055\/s-0044-1782675"},{"key":"4569_CR53","doi-asserted-by":"publisher","unstructured":"Bhattacharjee I, Friedman N, Rodriguez RJ. Utility of Rapid Exome Sequencing in the Diagnosis of a Rare Congenital Myasthenic Syndromes in a Preterm Infant. Journal of Pediatric Neurology. 2021;19(1):59\u201361. Available from: http:\/\/www.thieme-connect.com\/products\/ejournals\/html\/https:\/\/doi.org\/10.1055\/s-0040-1712177. Cited 2025 Sep 7.","DOI":"10.1055\/s-0040-1712177"},{"key":"4569_CR54","doi-asserted-by":"crossref","unstructured":"Boon HTM, Jacobs B, Wouter VR, Kamsteeg EJ, Kuks JBM, Vincent A, et al. Slow Channel Syndrome Revisited: 40 Years Clinical Follow-Up and Genetic Characterization of Two Cases. J Neuromuscul Dis. 2022;9(4):525\u201332. Available from:\u00a0https:\/\/scholar.google.com\/scholar_url?url=https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-220798&hl=en&sa=T&oi=ucasa&ct=ufr&ei=Aay8aKTVAozSieoP3YSb4Q4&scisig=AAZF9b8Y_-6V-_eMwCQcUZ13Sgly. Cited 2025 Sep 7.","DOI":"10.3233\/JND-220798"},{"key":"4569_CR55","doi-asserted-by":"crossref","unstructured":"Naveen A, Pujar MS, Revankar R, Rotti S. Divergent Phenotypes with Same CHRNE Mutation in Two Siblings with Congenital Myasthenic Syndrome. Indian Pediatrics Case Reports. 2024;4(2):95\u20138. Available from: https:\/\/journals.lww.com\/ipcr\/fulltext\/2024\/04020\/divergent_phenotypes_with_same_chrne_mutation_in.8.aspx. Cited 2025 Sep 7.","DOI":"10.4103\/ipcares.ipcares_143_23"},{"key":"4569_CR56","doi-asserted-by":"publisher","unstructured":"Bauch\u00e9 S, Sureau A, Sternberg D, Rendu J, Buon C, Mess\u00e9ant J, et al. New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes. Neurol Genet. 2020;6(6):e534. Available from: https:\/\/www.neurology.org\/doi\/pdf\/https:\/\/doi.org\/10.1212\/NXG.0000000000000534. Cited 2025 Sep 7.","DOI":"10.1212\/NXG.0000000000000534"},{"key":"4569_CR57","doi-asserted-by":"crossref","unstructured":"Carvalho I V., Jorge A, Rebelo O, Matos A. DOK7-Associated Congenital Myasthenic Syndrome: A Differential Diagnosis of Core Myopathies? Sinapse. 2024;23(4):230\u20131. Available from: https:\/\/sinapse.pt\/index.php\/journal\/article\/view\/10. Cited 2025 Sep 7.","DOI":"10.46531\/sinapse\/CE\/230073\/2023"},{"issue":"6","key":"4569_CR58","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ajhg.2015.10.017","volume":"97","author":"CV Logan","year":"2015","unstructured":"Logan CV, Cossins J, Rodr\u00edguez Cruz PM, Parry DA, Maxwell S, Mart\u00ednez-Mart\u00ednez P, et al. Congenital myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII \u03b11 chain. Am J Hum Genet. 2015;97(6):878\u201385.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"4569_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/qjmed\/hcac017","volume":"115","author":"K Tayade","year":"2022","unstructured":"Tayade K, Salunkhe M, Agarwal A, Radhakrishnan DM, Srivastava AK. DOK7 congenital myasthenic syndrome responsive to oral salbutamol. QJM: An International Journal of Medicine. 2022;115(5):323\u20134. https:\/\/doi.org\/10.1093\/qjmed\/hcac017.","journal-title":"QJM: An International Journal of Medicine"},{"key":"4569_CR60","doi-asserted-by":"crossref","unstructured":"Tsao CY. Effective Treatment with Albuterol in DOK7 Congenital Myasthenic Syndrome in Children. Pediatr Neurol. 2016;54:85\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26552645\/. Cited 2025 Sep 7.","DOI":"10.1016\/j.pediatrneurol.2015.09.019"},{"key":"4569_CR61","doi-asserted-by":"crossref","unstructured":"Maramattom BV, Patil R, Thomas J. Familial Dok7 congenital myasthenic syndrome responsive to Salbutamol. Neurol India. 2014;62(3):313\u20134. Available from: https:\/\/journals.lww.com\/neur\/fulltext\/2014\/62030\/familial_dok7_congenital_myasthenic_syndrome.17.aspx. Cited 2025 Sep 7.","DOI":"10.4103\/0028-3886.136999"},{"key":"4569_CR62","doi-asserted-by":"crossref","unstructured":"Lorenzoni PJ, Scola RH, Kay CSK, Filla L, Miranda APP, Pinheiro JMR, et al. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation. J Neurol Sci. 2013;331(1\u20132):155\u20137. Available from: https:\/\/www.jns-journal.com\/action\/showFullText?pii=S0022510X13002244. Cited 2025 Sep 7.","DOI":"10.1016\/j.jns.2013.05.017"},{"key":"4569_CR63","doi-asserted-by":"crossref","unstructured":"Mendpara V, Bethanabotla S, Yadav M, Kanisetti V, Singh G, Das A, et al. When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation. Cureus. 2023;15(5). Available from: https:\/\/cureus.com\/articles\/152443-when-breathing-becomes-a-challenge-a-case-of-congenital-myasthenia-gravis-in-an-indian-neonate-with-a-dok-7-gene-mutation. Cited 2025 Sep 7.","DOI":"10.7759\/cureus.38842"},{"key":"4569_CR64","doi-asserted-by":"crossref","unstructured":"Liewluck T, Selcen D, Engel AG. BeneficiaL Effects of Albuterol in Congenital Endplate Acetylcholinesterase deficiency and DOK-7 Myasthenia. Muscle Nerve. 2011;44(5):789. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3196786\/. Cited 2025 Sep 7.","DOI":"10.1002\/mus.22176"},{"key":"4569_CR65","doi-asserted-by":"crossref","unstructured":"Xia P, Xie F, Zhou ZJ, Lv W. Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome. Internal Medicine. 2021;61(6):887. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8987244\/. Cited 2025 Sep 7.","DOI":"10.2169\/internalmedicine.7774-21"},{"key":"4569_CR66","doi-asserted-by":"crossref","unstructured":"Ziaadini B, Ghaderi Yazdi B, Dirandeh E, Boostani R, Karimi N, Panahi A, et al. DOK7 congenital myasthenic syndrome: case series and review of literature. BMC Neurol. 2024;24(1):1\u20139. Available from:\u00a0https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03713-0. Cited 2025 Sep 7.","DOI":"10.1186\/s12883-024-03713-0"},{"key":"4569_CR67","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez Cruz PM, Palace J, Ramjattan H, Jayawant S, Robb SA, Beeson D. Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes. Neurology. 2015;85(12):1043. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4603597\/. Cited 2025 Sep 7.","DOI":"10.1212\/WNL.0000000000001952"},{"key":"4569_CR68","doi-asserted-by":"crossref","unstructured":"Durmus H, Shen XM, Serdaroglu-Oflazer P, Kara B, Parman-Gulsen Y, Ozdemir C, et al. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up. Neuromuscular Disorders. 2018;28(4):315\u201322. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29395675\/. Cited 2025 Sep 7.","DOI":"10.1016\/j.nmd.2017.11.013"},{"key":"4569_CR69","doi-asserted-by":"crossref","unstructured":"El Kadiri Y, Ratbi I, Sefiani A, Lyahyai J. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature. BMC Neurol. 2022;22(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35932018\/. Cited 2025 Sep 7.","DOI":"10.1186\/s12883-022-02822-y"},{"key":"4569_CR70","doi-asserted-by":"crossref","unstructured":"Almatrafi AM, Alluqmani MM, Basit S. Homozygous Duplication in the CHRNE in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up. Biomedicines. 2023;11(11):2983. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10668953\/. Cited 2025 Sep 7.","DOI":"10.3390\/biomedicines11112983"},{"key":"4569_CR71","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Garc\u00eda de la Banda M, Simental-Aldaba E, Fahmy N, Sternberg D, Blondy P, Quijano-Roy S, et al. Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings. Front Neurol. 2022;13:909715. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9201482\/. Cited 2025 Sep 7.","DOI":"10.3389\/fneur.2022.909715"},{"key":"4569_CR72","doi-asserted-by":"crossref","unstructured":"Hesami O, Ramezani M, Ghasemi A, Fatehi F, Okhovat AA, Ziaadini B, et al. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum. Orphanet J Rare Dis. 2024;19(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38475910\/. Cited 2025 Sep 7.","DOI":"10.1186\/s13023-024-03116-x"},{"key":"4569_CR73","doi-asserted-by":"crossref","unstructured":"Chan SHS, Wong VCN, Engel AG. Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol. Pediatr Neurol. 2012;47(2):137\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22759693\/. Cited 2025 Sep 7.","DOI":"10.1016\/j.pediatrneurol.2012.04.022"},{"key":"4569_CR74","doi-asserted-by":"crossref","unstructured":"Giarrana ML, Joset P, Sticht H, Robb S, Steindl K, Rauch A, et al. A severe congenital myasthenic syndrome with \u201cdropped head\u201d caused by novel MUSK mutations. Muscle Nerve. 2015;52(4):668\u201373. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25900532\/. Cited 2025 Sep 7.","DOI":"10.1002\/mus.24687"},{"key":"4569_CR75","unstructured":"Ardissone A, Moroni I, Bernasconi P, Brugnoni R. Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in CHRNE gene. Acta Myologica. 2017;36(1):28. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5479107\/. Cited 2025 Sep 7."},{"key":"4569_CR76","doi-asserted-by":"crossref","unstructured":"Mroczek M, Durmus H, T\u00f6pf A, Parman Y, Straub V. Four individuals with a homozygous mutation in exon 1f of the plec gene and associated myasthenic features. Genes (Basel). 2020;11(7):1\u201312. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32605089\/. Cited 2025 Sep 7.","DOI":"10.3390\/genes11070716"},{"key":"4569_CR77","doi-asserted-by":"crossref","unstructured":"Ma Y, Xiong T, Lei G, Ding J, Yang R, Li Z, et al. Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles. Neurological Sciences. 2021;42(8):3485\u201390. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33438142\/. Cited 2025 Sep 7.","DOI":"10.1007\/s10072-020-05021-0"},{"key":"4569_CR78","doi-asserted-by":"crossref","unstructured":"Maselli RA, V\u00e1zquez J, Schrumpf L, Arredondo J, Lara M, Strober JB, et al. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A. Mol Genet Genomic Med. 2018;6(3):434\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29441694\/. Cited 2025 Sep 7.","DOI":"10.1002\/mgg3.370"},{"key":"4569_CR79","doi-asserted-by":"crossref","unstructured":"Xia P, Xie F, Zhou ZJ, Lv W. Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome. Internal Medicine. 2022;61(6):887\u201390. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34433720\/. Cited 2025 Sep 7.","DOI":"10.2169\/internalmedicine.7774-21"},{"key":"4569_CR80","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez Cruz PM, Belaya K, Basiri K, Sedghi M, Farrugia ME, Holton JL, et al. Clinical features of the myasthenic syndrome arising from mutations in GMPPB. J Neurol Neurosurg Psychiatry. 2016;87(8):802\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27147698\/. Cited 2025 Sep 7.","DOI":"10.1136\/jnnp-2016-313163"},{"key":"4569_CR81","doi-asserted-by":"crossref","unstructured":"Ziaadini B, Ghaderi Yazdi B, Dirandeh E, Boostani R, Karimi N, Panahi A, et al. DOK7 congenital myasthenic syndrome: case series and review of literature. BMC Neurol. 2024;24(1):1\u20139. Available from:\u00a0https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03713-0. Cited 2025 Sep 3.","DOI":"10.1186\/s12883-024-03713-0"},{"key":"4569_CR82","doi-asserted-by":"crossref","unstructured":"Shao S, Shi G, Bi FF, Huang K. Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by COLQ Mutations. Curr Neuropharmacol. 2023;21(7):1594. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10472815\/. Cited 2025 Sep 3.","DOI":"10.2174\/1570159X21666230126145652"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04569-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:44:25Z","timestamp":1770648265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04569-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4569"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04569-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a systematic review of previously published studies. No new human or animal studies were conducted by the authors. So consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}